2016年1月13日星期三
Betaxolol hydrochloride
Product name:Betaxolol hydrochloride
CAS: 63659-19-8
Molecular Formula: C18H30ClNO3
Molecular Weight: 343.89
Product description:Selective beta 1 receptor blocker, no inner fitting the sympathetic activity and membrane stability. For beta 1 receptor selectivity than atenolol and thor slightly higher. To the action of the heart and other beta blockers. The blood vessels and the effect of bronchial smooth muscle is weak. Also can reduce the plasma renin activity.Suitable for the treatment of chronic primary open-angle glaucoma, high intraocular pressure; Is required for a high intraocular pressure caused by primary closed-angle glaucoma with eye medicine.
From:http://www.acridine-raw-material.com/Pharmaceutical-APIS/Betaxolol-hydrochloride/
Would like to ask specific details, please click here Email:sales@acridine-raw-material.com
Dimethyl-D-tartrate
Product name:Dimethyl-D-tartrate
CAS: 13171-64-7
Molecular Formula:C6H10O6
Formula Weight:178.14
Description:
Melting point:48-50 ºC
Boiling point:157-159 ºC (11 mmHg),280 °C at 760 mmHg
Flash Point:95.7 °C
Density:1.367 g/cm3
Chemical property:White mass solid or colorless oil-like liquid
Use:Used mainly for chiral drugs
Would like to ask specific details, please click here Email:sales@acridine-raw-material.com
Women scientists to funding more difficult to apply?
Women scientists from the American government to apply for research funding will be less than their male counterparts do? The earliest a cross-sectoral survey: sometimes true. However, the Government Accountability Office (GAO) raised some objections: because some agencies did not get the necessary data before making conclusions, GAO hopes to find new ways to figure out this problem - this is the three Democratic Women MPs requirements; In addition, even the existence of differences in terms of grant applications, but may not lead to discrimination due to gender; and finally, some of the IMF did not follow the strict legal requirements to track major colleges and universities in the allocation of funds in compliance with the principle of gender equality .
GAO wish success rate in grant applications as indicators of whether women receive different treatment. It is collected from 2009 to 2013 to study funded by six IMF (ranging from basic research to applied research, from theoretical science to engineering sciences, etc., account for 90% of the entire US research funding) application data. The results show: the two largest IMF: NIH and NSF, the female and male scientist in the grant application success rates are similar.
But there are also bad news: the data Energy Sciences Office of the Defense Office of Naval given, the success rate of male funding applications 7% and 6%, respectively, than women. But because the two institutions are not systematically collect the applicant's materials, it is difficult to directly answer whether there is gender discrimination.
However, the lack of data is not blocked GAO determination. They NSF conducted "Dr. survey respondents' questionnaire results are analyzed, the survey data on the sources of funding include nearly one million scientists and engineers have their own submission. These data can provide information on whether they are subject to gender-based discrimination in accepting funding from NIH, NSF, DOE and DOD and other agencies.
Overall data show that: women scientists in NIH funding by one-third more than the men. However, DOE, women get funded only one-third of men.
GAO believes that the main reason for this difference is the difference between the applicant group. Women researchers focused on the biomedical field, but relatively few physical sciences and engineering fields related to DOE and DOD support. This makes women in NIH, NSF range is funded within rather than men.
Bolise Co., Ltd.
GAO wish success rate in grant applications as indicators of whether women receive different treatment. It is collected from 2009 to 2013 to study funded by six IMF (ranging from basic research to applied research, from theoretical science to engineering sciences, etc., account for 90% of the entire US research funding) application data. The results show: the two largest IMF: NIH and NSF, the female and male scientist in the grant application success rates are similar.
But there are also bad news: the data Energy Sciences Office of the Defense Office of Naval given, the success rate of male funding applications 7% and 6%, respectively, than women. But because the two institutions are not systematically collect the applicant's materials, it is difficult to directly answer whether there is gender discrimination.
However, the lack of data is not blocked GAO determination. They NSF conducted "Dr. survey respondents' questionnaire results are analyzed, the survey data on the sources of funding include nearly one million scientists and engineers have their own submission. These data can provide information on whether they are subject to gender-based discrimination in accepting funding from NIH, NSF, DOE and DOD and other agencies.
Overall data show that: women scientists in NIH funding by one-third more than the men. However, DOE, women get funded only one-third of men.
GAO believes that the main reason for this difference is the difference between the applicant group. Women researchers focused on the biomedical field, but relatively few physical sciences and engineering fields related to DOE and DOD support. This makes women in NIH, NSF range is funded within rather than men.
Bolise Co., Ltd.
HCCLM3
Product name:HCCLM3
Species:Human
Source:Liver cancer, lung metastases
Morphology: Epithelial
Medium and additives:DMEM and 10% fetal bovine serum
Application:Only for research purposes
Product description:
This is the employing hepatoma cell line MHCC97-H inoculated in nude mice, conducting three times lung metastasis screening,and the completion of the lung metastases were inoculated subcutaneously with a high degree of spontaneous lung metastasis after liver cancer cell lines.
Please click here Email:sales@growth-media.net
2016年1月12日星期二
BT474
Product name:BT474
Species:Human
Gender:Female
Source:Ductal breast cancer
Morphology:Epithelial
Medium and additives:
Hybri-Care medium (modified Dulbecco medium), 90%; FBS 10%
Application:Only for research purposes
Product description:
BT-474 cell line was isolated from a solid invasive ductal carcinoma.
E-mail inquiry:sales@growth-media.net
BEL-7404
Product name:BEL-7404
Species:Human
Source:Liver
Morphology: Epithelial
Medium and additives:
RPMI 1640 + 10% fetal bovine serum or newborn bovine serum.
Application:For research purposes
Product description:
This can not be detected in cells 1.3kb LFIRE-1/HFREP-1 mRNA expression by Northern blot method.
E-mail inquiry:sales@growth-media.net
NCI-H520 for sale
Growth Properties: adherent
Morphology: epithelial
Organ: lung
Product description:
The cells expressgreatly reduced levels of p53 mRNA relative to normal lung tissue, but exhibit no gross structural DNA abnormalities.
The cells stain positively for keratin and vimentin but are negative for neurofilament triplet protein.
The line can be cloned in soft agar (with or without serum).
Morphology: epithelial
Organ: lung
Product description:
The cells expressgreatly reduced levels of p53 mRNA relative to normal lung tissue, but exhibit no gross structural DNA abnormalities.
The cells stain positively for keratin and vimentin but are negative for neurofilament triplet protein.
The line can be cloned in soft agar (with or without serum).
Please click here Email:sales@growth-media.net
订阅:
博文 (Atom)